Company profile: Semler Scientific
1.1 - Company Overview
Company description
- Provider of medical risk-assessment solutions, including QuantaFlo software for non-invasive vascular disease risk assessment by evaluating extremity blood flow; SemlerShield for protection and security of medical data; SemlerVault for secure storage of sensitive medical information; SemlerAnalytics for insights and analytics on medical data; and SemlerSimulation, an online simulation-based training program for medical professionals.
Products and services
- QuantaFlo: Non-invasive medical device software used for vascular disease risk assessment, providing testing to evaluate blood flow in the extremities and enabling vascular disease risk assessment based on extremity blood-flow evaluation
- SemlerVault: Secure storage solution for sensitive medical data and information, delivering secure storage for sensitive medical data and information to keep sensitive medical information securely stored
- SemlerShield: Security service offering protection and security for medical data and information, supplying protection and security for medical data and information as a dedicated security service
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Semler Scientific
Nectero Medical
HQ: United States
Website
- Description: Provider of a minimally invasive treatment to stabilize growth and prevent rupture of small to mid-sized abdominal aortic aneurysms through the Nectero EAST® System, which uses a dual-balloon catheter to deliver a stabilizer mixture to strengthen the aortic wall; includes the stAAAble Trial to evaluate safety and efficacy in patients with infrarenal abdominal aortic aneurysms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nectero Medical company profile →
Vitalitec
HQ: United States
Website
- Description: Provider of niche vascular, cardio-vascular, and endoscopic products, with core strengths in specialty instrumentation and vessel occlusion, both permanent and temporary. Develops, manufactures and markets to high quality standards at a reasonable cost.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vitalitec company profile →
CardiAQ Valve Technologies
HQ: United States
Website
- Description: Provider of innovative heart valve replacement solutions, initially focused on transcatheter mitral valve implantation (TMVI), a minimally invasive catheter-based procedure for replacing the heart's mitral valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardiAQ Valve Technologies company profile →
Truvic Medical
HQ: United States
Website
- Description: Provider of devices for single-session thrombus removal without thrombolytics, including Symphony, a device that uses continuous aspiration and mechanical assistance to engage and disrupt clots, and Prodigy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Truvic Medical company profile →
Capricor
HQ: United States
Website
- Description: Provider of cell and exosome-based therapeutics, including CAP-1002, an allogeneic cardiosphere-derived cell therapy in Phase 3 for Duchenne muscular dystrophy; the StealthX exosome platform for designer protein surface expression, cargo loading and targeted delivery to enable precision therapeutics and vaccines; and an exosome-based multivalent SARS-CoV-2 vaccine under development with the NIH.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capricor company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Semler Scientific
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Semler Scientific
2.2 - Growth funds investing in similar companies to Semler Scientific
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Semler Scientific
4.2 - Public trading comparable groups for Semler Scientific
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →